Fatty liver disease does not directly cause infertility in most women, but it creates a chain of hormonal and metabolic disruptions that can make it significantly harder to conceive. The connection runs through insulin resistance, elevated androgen levels, and impaired hormone processing, all of which interfere with ovulation. Women with fatty liver disease also share a striking overlap with polycystic ovary syndrome (PCOS), one of the most common causes of female infertility.
How Your Liver Controls Reproductive Hormones
Your liver does more than filter toxins. It produces a protein called sex hormone-binding globulin (SHBG), which acts like a shuttle for sex hormones in your blood. SHBG binds to testosterone and keeps it inactive. Only about 1 to 2 percent of testosterone in a woman’s bloodstream is free and active at any given time; roughly 65 percent is locked up by SHBG.
When fat accumulates in the liver, this system breaks down. The excess fat triggers insulin resistance, which in turn suppresses the genes responsible for making SHBG. With less SHBG circulating, more testosterone floats freely through the body. A woman can have a perfectly normal total testosterone reading on a blood test yet still have elevated levels of the active, unbound form. That surplus of free testosterone disrupts ovulation, thins the uterine lining, and can push the reproductive system toward the same dysfunction seen in PCOS.
The hormonal disruption doesn’t stop with androgens. A healthy liver metabolizes and clears estrogen efficiently. A fatty or scarred liver loses some of that capacity, allowing estrogen to build up. Excess circulating estrogen throws off the signals between the brain and the ovaries, specifically the pulses of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) that trigger egg release each month. In women with cirrhosis, the most advanced form of liver disease, LH and FSH levels are measurably lower than in healthy women, which helps explain why more than 45 percent of women with cirrhosis awaiting a transplant have absent or irregular periods.
The PCOS Overlap
PCOS and fatty liver disease share so many underlying drivers that they frequently show up together. In a study of young South Asian women with PCOS and no known liver problems, nearly 40 percent were found to have fatty liver disease when screened with imaging, compared to just 8 percent in a control group. About 7 percent already had significant scarring (fibrosis) of the liver.
The two conditions feed each other through insulin resistance, chronic low-grade inflammation, and abnormal blood lipids. But the strongest independent predictor of fatty liver in women with PCOS was hyperandrogenism, the excess of male hormones. Women with elevated androgens had more than five times the odds of also having fatty liver, even after adjusting for insulin resistance. Obesity was the other major factor, with each unit increase in BMI raising the odds by about 30 percent. Emerging evidence also points to altered gut bacteria as a shared driver of both conditions, though the practical implications of that link are still being worked out.
If you have PCOS and are struggling to conceive, it may be worth asking about fatty liver screening. The liver component is often overlooked because these women are typically young and don’t have obvious symptoms of liver disease.
Effects on Egg Quality
Beyond preventing ovulation, the metabolic environment created by fatty liver disease can damage the eggs themselves. Insulin resistance and elevated circulating fatty acids change the composition of the fluid surrounding developing eggs inside the ovary. Specifically, higher concentrations of certain fatty acids (oleic acid and stearic acid) in follicular fluid are linked to poorer egg quality and worse embryo development.
Research on women with PCOS undergoing IVF found that embryo fragmentation on day three, a sign of lower viability, correlated directly with oleic acid levels in the follicular fluid, regardless of whether the woman was obese. In obese women with PCOS, stearic acid levels were negatively correlated with the quality of individual cells within the embryo. Animal studies reinforce this pattern: eggs from insulin-resistant mice show delayed maturation, smaller size, and increased cell death in the surrounding support cells.
This means that even when ovulation does occur, either naturally or with medical help, the resulting egg may be less likely to develop into a healthy embryo. Addressing insulin resistance and fatty liver can improve this metabolic environment before conception is attempted.
Fertility Treatment Outcomes
Having liver disease does not rule out IVF or other assisted reproduction. In a study of women with liver-related conditions who underwent IVF, 75 percent of cycles resulted in successful implantation, and the live birth rate among those implantations was 74 percent. Even women with cirrhosis or prior liver transplants achieved pregnancies, though their success rates per cycle were somewhat lower.
The more relevant concern for most women with fatty liver is that the underlying metabolic problems, insulin resistance, inflammation, hormonal imbalances, can reduce the effectiveness of fertility treatments if left unaddressed. Improving insulin sensitivity through weight loss, exercise, or medication often improves ovulation rates and egg quality before IVF is even necessary.
Risks During Pregnancy
Conceiving is only part of the picture. Fatty liver disease raises the odds of several serious pregnancy complications, and this risk appears to be independent of body weight alone. A 2022 meta-analysis pooling data from multiple countries found that women with fatty liver disease faced roughly three times the odds of developing gestational diabetes (with rates between 20 and 30 percent), about 2.4 times the odds of preeclampsia, and double the odds of preterm birth compared to women without liver disease.
A large U.S. study using national hospital data found the odds of severe hypertensive complications (preeclampsia, eclampsia, or a dangerous condition called HELLP syndrome) were more than threefold higher in pregnancies with fatty liver disease than in pregnancies with no liver disease or even other types of chronic liver disease. This suggests something specific about fatty liver’s metabolic effects, not just general illness, drives these risks. A Chinese study reinforced this by showing that even women with fatty liver and a normal BMI had elevated preeclampsia risk, ruling out weight as the sole explanation.
What Actually Helps
The good news is that fatty liver disease in its earlier stages is reversible, and improving it can improve fertility. The same interventions that reduce liver fat also address the hormonal disruptions that interfere with conception.
- Weight loss of 5 to 10 percent has been shown to reduce liver fat, improve insulin sensitivity, lower free androgen levels, and restore ovulation in many women with PCOS. Even modest changes matter.
- Exercise improves insulin sensitivity independent of weight loss. Both aerobic activity and resistance training help reduce liver fat.
- Dietary changes that reduce refined carbohydrates and added sugars have the most direct impact on liver fat. A Mediterranean-style eating pattern is the most studied approach for fatty liver improvement.
- Insulin-sensitizing medications are sometimes used to address the underlying resistance, which can restore ovulation and improve egg quality in women who don’t respond to lifestyle changes alone.
If you have irregular periods, difficulty conceiving, and any metabolic risk factors like central obesity, high triglycerides, or elevated blood sugar, fatty liver disease may be a contributing factor that hasn’t been investigated. Screening typically involves a blood test for liver enzymes and an ultrasound, both simple and widely available. Treating the liver problem won’t just improve your chances of getting pregnant; it will also lower your risk of complications once you do.